Immutep ADR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep ADR and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap23.28M
Market cap23.28M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume58.17K
Average volume58.17K
High today$3.41
High today$3.41
Low today$3.09
Low today$3.09
Open price$3.41
Open price$3.41
Volume44.70K
Volume44.70K
52 Week high$70.60
52 Week high$70.60
52 Week low$2.66
52 Week low$2.66
IMMP News
TipRanks 2d
Immutep Reports EFTISARC-NEO Disease-Free Survival Data in Soft Tissue SarcomaImmutep ( (IMMP) ) has issued an update. Immutep is a clinical-stage biotechnology company developing LAG-3 immunotherapies for cancer and autoimmune diseases....
Benzinga 3d
Immutep Reports 81.1% Disease-Free Survival Rate in Soft Tissue Sarcoma Trial - Benzinga...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.